5-Carbamoyl-5H-dibenz[b,f]azepinEN5-Cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine | 356760-08-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 5-Carbamoyl-5H-dibenz[b,f]azepinEN5-Cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine
• 英文别名: 5-cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine；5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine；5-Cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepin；10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carbonitrile；5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carbonitrile
• CAS: 356760-08-2
• 化学式: C₁₅H₁₂N₂O
• 分子量: 236.273
• InChiKey: QQSMCHOABQHASF-UHFFFAOYSA-N

物化性质

• 沸点：
  430.8±45.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  47.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-Carbamoyl-5H-dibenz[b,f]azepinEN5-Cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine 在 sodium perborate 、 乙醇 、 水 、 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 27.5h， 以72%的产率得到艾司利卡西平
  参考文献：
  名称：

  WO2006/56339

  摘要：

  公开号：
• 作为产物：
  描述：

  10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbonitrile 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 作用下， 以 正己烷 、 水 、 氯苯 为溶剂， 以3.68 g (52%)的产率得到5-Carbamoyl-5H-dibenz[b,f]azepinEN5-Cyano-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine
  参考文献：
  名称：

  5-CYANO-10-HYDROXY-10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE, THE PROCESSES FOR ITS PREPARATION AND FOR ITS CONVERSION INTO 5-CARBAMOYL-10-OXO-10, 11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE OR INTO 5-CARBAMOYL-5H-DIBENZ[B,F]AZEPINE

  摘要：

  5-氰基-10-羟基-10,11-二氢-5H-二苯并[b,f]氮杂环庚烷及其制备方法。

  公开号：

  US06384217B1

文献信息

• PROCESS FOR THE PREPARATION OF (S)-(+)- OR (R)-(-)-10-HYDROXY DIHYDRODIBENZ[B,F]AZEPINES BY ENANTIOSELECTIVE REDUCTION OF 10,11-DIHYDRO-10-OXO-5H-DIBENZ[B,F]AZEPINES AND POLYMORPHS THEREOF
  申请人：Biswas Sujay

  公开号：US20130345198A1

  公开（公告）日：2013-12-26

  The present invention provides a novel process for the preparation of substituted optically pure (S)-(+)- or (R)-(−)-10-hydroxy-dihydrodibenz[b,f]azepines or derivatives thereof, starting from 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepines using boronate esters or their derivatives. The present invention also provides use of thus prepared (S)-(+)- or (R)-(−)-10-hydroxy-dihydrodibenz[b,f]azepines for the preparation of their ester such as (S)-(−)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide or (R)-(+)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide. The present invention also provides novel solid state crystalline forms J 1 , J 2 , J 3 , J 4 and amorphous form of eslicarbazepine and the process for the preparation thereof. Also, the present invention provides novel solid state crystalline form and amorphous form of eslicarbazepine acetate and the process for the preparation thereof. The novel solid state forms of eslicarbazepine are useful for the preparation of derivatives of eslicarbazepine such as eslicarbazepine acetate.

  本发明提供了一种新颖的方法，用于从10,11-二氢-10-氧代-5H-二苯并[b,f]氮杂环己烯起始，利用硼酸酯或其衍生物制备取代的光学纯(S)-(+)-或(R)-(-)-10-羟基-二氢二苯并[b,f]氮杂环己烯或其衍生物。本发明还提供了利用这样制备的(S)-(+)-或(R)-(-)-10-羟基-二氢二苯并[b,f]氮杂环己烯制备它们的酯，如(S)-(-)-10-乙酰氧基-10,11-二氢-5H-二苯并[b,f]氮杂环己烯-5-羧酰胺或(R)-(+)-10-乙酰氧基-10,11-二氢-5H-二苯并[b,f]氮杂环己烯-5-羧酰胺。本发明还提供了新颖的固态结晶形式J1、J2、J3、J4和eslicarbazepine的非晶态形式及其制备方法。此外，本发明提供了eslicarbazepine乙酸盐的新颖固态结晶形式和非晶态形式以及其制备方法。eslicarbazepine的新颖固态形式对于制备eslicarbazepine乙酸盐等eslicarbazepine的衍生物非常有用。
• PROCESS FOR THE PREPARATION AND PURIFICATION OF ESLICARBAZEPINE ACETATE AND INTERMEDIATES THEREOF
  申请人：Hirpara Ketan

  公开号：US20150065704A1

  公开（公告）日：2015-03-05

  The present invention provides a novel process for the preparation of 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, commonly known as oxcarbazepine, which is a medicament and a useful intermediate in the preparation of eslicarbazepine acetate. The present invention further provides a process for the preparation and purification of eslicarbazepine acetate.

  本发明提供了一种新颖的制备10-氧代-10,11-二氢-5H-二苯并[b,f]氮杂环庚-5-甲酰胺，通常称为奥卡西平（oxcarbazepine）的方法，该化合物是一种药物，也是制备艾司卡西平乙酸酯的有用中间体。本发明还提供了一种制备和纯化艾司卡西平乙酸酯的方法。
• Process For The Preparation Of 10,11-Dihydro-10-Hydroxy-5H-Dibenz[B,F]Azepine-5-Carboxyamide
  申请人：Panunzio Mauro

  公开号：US20080221320A1

  公开（公告）日：2008-09-11

  A process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxyamide by hydrolysis of 5-cyano-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine with peroxy compounds in alkali medium and in the presence of solvents.

  通过在碱性介质中和溶剂存在的情况下，使用过氧化物水解5-氰基-10,11-二氢-10-羟基-5H-二苯并[b,f]氮杂环庚烷-5-羧酰胺的制备过程。
• [EN] PROCESS FOR THE PREPARATION OF (S)-(+)-OR (R)-(-)-10 HYDROXY DIHYDRODIBENZ[B,F]AZEPINES BY ENANTIOSELECTIVE REDUCTION OF 10, 11-DIHYDRO-10-OXO-5H-DIBENZ[B,F]AZEPINES AND POLYMORPHS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE (S)-(+)- OU (R)-(-)-10-HYDROXYDIHYDRODIBENZ[B,F]- AZÉPINES PAR RÉDUCTION ÉNANTIOSÉLECTIVE DE 10,11-DIHYDRO-10-OXO-5H- DIBENZ[B,F]AZÉPINES ET DE POLYMORPHES DE CELLES-CI
  申请人：JUBILANT LIFE SCIENCES LTD

  公开号：WO2012120356A2

  公开（公告）日：2012-09-13

  The present invention provides a novel process for the preparation of substituted optically pure (S)-(+)- or (R)-(-)-10-hydroxy-dihydrodibenz[b,f]azepines or derivatives thereof, starting from 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepines using boronate esters or their derivatives. The present invention also provides use of thus prepared (S)-(+)- or (R)-(-)- 10-hydroxy-dihydrodibenz[b,f]azepines for the preparation of their ester such as (S)-(-)- 10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide, or (R)-(+)-10-acetoxy- 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide. The present invention also provides novel solid state crystalline forms J1, J2, J3, J4 and amorphous form of eslicarbazepine and the process for the preparation thereof. Also, the present invention provides novel solid state crystalline form and amorphous form of eslicarbazepine acetate and the process for the preparation thereof. The novel solid state forms of eslicarbazepine are useful for the preparation of derivatives of eslicarbazepine such as eslicarbazepine acetate.

  本发明提供了一种新型的过程，用硼酸酯或其衍生物从10,11-二氢-10-氧代-5H-二苯并[b,f]氮杂环制备取代的光学纯(S)-(+)-或(R)-(-)-10-羟基-二氢-二苯并[b,f]氮杂环或其衍生物。本发明还提供了利用这样制备的(S)-(+)-或(R)-(-)-10-羟基-二氢-二苯并[b,f]氮杂环制备它们的酯，例如(S)-(-)-10-乙酰氧基-10,11-二氢-5H-二苯并[b,f]氮杂环-5-羧酰胺或(R)-(+)-10-乙酰氧基-10,11-二氢-5H-二苯并[b,f]氮杂环-5-羧酰胺。本发明还提供了新的固态晶体形式J1、J2、J3、J4和eslicarbazepine的非晶态形式及其制备过程。此外，本发明还提供了eslicarbazepine乙酸盐的新的固态晶体形式和非晶态形式及其制备过程。eslicarbazepine的新的固态形式对于制备eslicarbazepine乙酸盐等eslicarbazepine衍生物非常有用。
• WO2006/53674
  申请人：——

  公开号：——

  公开（公告）日：——